Antibody–Drug Conjugates Targeting HER2 and Trop-2: A New Force in Precision Treatment for Solid Tumors
Key clinical data and application prospects in breast cancer, gastric cancer, non-small cell lung cancer, and urothelial carcinoma are summarized and analyzed, while also delving into the challenges and future directions within this field.